| Patent application number | Description | Published |
| 20080213918 | Polynucleotides encoding two novel human G-protein coupled receptors, HGPRBMY28 and HGPRBMY29, and splice variants thereof - The present invention provides novel polynucleotides encoding HGPRBMY28 and HGPRBMY29 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding splice variants of HGPRBMY29 polypeptides, HGPRBMY29v1 and HGPRBMY29v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY28, HGPRBMY29, HGPRBMY29v1, and HGPRBMY29v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention. | 09-04-2008 |
| 20080274505 | Polynucleotide encoding a novel TRP channel family member, LTRPC3, and splice variants thereof - The present invention provides novel polynucleotides encoding LTRPC3 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants and splice variants of LTRPC3 polypeptides, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f, respectively. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LTRPC3, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention. | 11-06-2008 |
| 20080318257 | Polynucelotides encoding novel variants of the TRP channel family member, LTRPC3 - The present invention provides novel polynucleotides encoding LTRPC3g, LTRPC3h, LTRPC3i, LTRPC3j, LTRPC3k, or LTRPC3l polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LTRPC3g, LTRPC3h, LTRPC3i, LTRPC3j, LTRPC3k, or LTRPC3l polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention. | 12-25-2008 |
| 20090088385 | Antibodies that bind to BGS-4 - The present invention provides novel polynucleotides encoding BGS-4 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing the polypeptides of the present invention. The invention further relates to diagnostic and therapeutic methods for applying these novel BGS-4 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention. | 04-02-2009 |
| 20100003736 | Polynucleotides encoding novel PCSK9 variants - The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention. | 01-07-2010 |
| 20110076742 | POLYNUCLEOTIDES ENCODING NOVEL PCSK9 VARIANTS - The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention. | 03-31-2011 |
| Patent application number | Description | Published |
| 20090018849 | Web-based over-the-air provisioning and activation of mobile terminals - In a method for over-the-air provisioning of a mobile terminal in a wireless network, a first transaction between the mobile terminal and a web server is performed via an external port. During the first transaction, the mobile terminal obtains user subscription information for subscribing to network services. During a second transaction between the web server and the mobile terminal, the mobile terminal obtains device management information for authorizing the mobile terminal to access the network services. The first and second transactions are conducted via the same external port. | 01-15-2009 |
| 20090197572 | Accessing networks for limited purposes - One method includes setting up an authenticated communication session between a mobile terminal and a first core data network. The method includes acquiring, at the first core data network, supplementary access data usable by the mobile terminal to set up a non-authenticated communication session with a second data network and then, transmitting the supplementary access data from the first core data network to the mobile terminal. The second data network is accessible to the mobile terminal. | 08-06-2009 |
| 20090233578 | Methods and apparatuses for dynamic management of security associations in a wireless network - Methods for dynamic management of security associations in a network are provided. According to one method, a security key management entity determines whether to apply a new security key as an active security key based on an existing active security key. Each of the new security key and the existing active security key are associated with a same home agent, and the existing active security key serves as a basis for an existing security association between the home agent and at least one other network element. | 09-17-2009 |
| 20090292909 | Methods for initial bootstrap of user terminals in network - Methods and devices for initial bootstrap of a user terminal are provided. The user terminal transmits at least one first message to an initial bootstrap server. The first message includes device management capability information for the user terminal. The initial bootstrap server selects a device management protocol to be used by the user terminal and sends the selected device management protocol to the user terminal in at least one second message. | 11-26-2009 |
| 20100202406 | Method And Apparatus For Managing Mobility Transactions Among Fixed/Nomadic Wireless Terminals - A method is provided for managing the mobility attempts for a Fixed/Nomadic wireless terminal so as to substantially limit those attempts to only requests for handoff to base stations within a restricted set to which handoff of the wireless terminal is permitted. In a particular embodiment, the method of the invention operates to prune the allowed base-station scan list, for a particular Fixed/Nomadic wireless terminal, when the particular wireless terminal requests a grant of scan durations from the serving base station. Since differentiation/restriction is applied at the scanning stage itself, the mobility attempts by the Fixed/Nomadic wireless terminal is limited and much more controlled, thus reducing spurious handoff attempts that need to be rejected by the serving base station or the serving gateway. | 08-12-2010 |